SMTL ID : 3qcu.2 (1 other biounit)

Crystal structure of the LT3015 antibody Fab fragment in complex with lysophosphatidic acid (14:0)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.98 Å

Oligo State

hetero-1-1-mer

Ligands

1 x NKN: (2R)-2-hydroxy-3-(phosphonooxy)propyl tetradecanoate(Non-covalent)

NKN.1: 18 residues within 4Å: Chain A: L.33, S.55, Y.57, F.100, G.101, Y.102, Y.103, G.104, S.105, G.106, N.107, Y.108 Chain B: N.35, Y.37, K.55, S.96, F.99, F.101 19 PLIP interactions: 12 interactions with chain A, 7 interactions with chain B Hydrophobic interactions: A:L.33, A:Y.57, A:Y.57, A:F.100, A:Y.102, A:Y.103, A:Y.103, B:F.99 Hydrogen bonds: A:G.101, A:G.104, A:S.105, A:G.106, A:N.107, B:N.35, B:S.96 Water bridges: B:Y.37, B:K.55, B:K.55 Salt bridges: B:K.55

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fleming, J.K. et al., Biochemical and structural characterization of lysophosphatidic Acid binding by a humanized monoclonal antibody. J.Mol.Biol. (2011)

Release Date

2011-03-30

Peptides

LT3015 antibody Fab fragment, heavy chain: A
LT3015 antibody Fab fragment, light chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
I

B
M

LT3015 antibody Fab fragment, heavy chain

LT3015 antibody Fab fragment, light chain

Related Entries With Identical Sequence